ArticleLeukemia & lymphoma2018

Life after ponatinib failure: outcomes of chronic and accelerated phase CML patients who discontinued ponatinib in the salvage setting.

Prajwal Boddu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.